WO2024201420 - MIRNA-484 INHIBITORS AND USES THEREOF

National phase entry is expected:
Publication Number WO/2024/201420
Publication Date 03.10.2024
International Application No. PCT/IB2024/053115
International Filing Date 29.03.2024
Title **
[English] MIRNA-484 INHIBITORS AND USES THEREOF
[French] INHIBITEURS DE MIARN-484 ET LEURS UTILISATIONS
Applicants **
BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-Gu Seongnam Gyeonggi-do 13494, KR
Inventors
RYU, Jin-Hyeob c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
JANG, Ha Na c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
LIM, Jongyeob c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
JUNG, Yeon-Joo c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
PARK, Young Jin c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
KIM, Insun c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
LIM, Yu Na c/o BIORCHESTRA CO., LTD. 2F-216, Venture-dong, KRIBB, 125, Gwahak-ro Yuseong-gu Daejeon 34141, KR
KANG, Howon c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
JOUNG, Chanmi c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
CHOI, Eunju c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
PARK, Ah Hyung c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
YOOK, Chaehyun c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
CHO, Seokhwan c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
SHIN, Yujin c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
GIL, So-Young c/o SK BIOPHARMACEUTICALS CO., LTD. 221, Pangyoyeok-ro, Bundang-gu Seongnam Gyeonggi-do 13494, KR
Priority Data
63/493,526   31.03.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing2406
EPO Filing, Examination18505
Japan Filing531
South Korea Filing575
USA Filing, Examination11835
MasterCard Visa

Total: 33852

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present disclosure includes the use of a miR-484 inhibitor for treating a disease or disorder associated with the increased level of miR-484. In some aspects, the miR-484 inhibitor is capable of reducing the expression of a gene and/or protein associated with miR-484.[French] La présente invention comprend l'utilisation d'un inhibiteur de miR-484 pour traiter une maladie ou un trouble associé au niveau accru de miR-484. Selon certains aspects, l'inhibiteur de miR-484 est capable de réduire l'expression d'un gène et/ou d'une protéine associés à miR-484.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙